Codex DNA Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

SAN DIEGO, June 22, 2021 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY) today announced the closing of its initial public offering of 7,666,664 shares of common stock, including the full exercise of the underwriters’ option to purchase up to 999,999 additional shares of common stock, at a public offering price of $16.00 per share. The aggregate gross proceeds to Codex DNA from the offering were approximately $122.7 million, before deducting underwriting discounts and commissions and other offering expenses. All of the shares in the offering were offered by Codex DNA. 

Click here to view original post